Skip to content

Utility of CO2 insufflator for diagnosis of irritable bowel syndrome (IBS)

Utility of CO2 insufflator for diagnosis of irritable bowel syndrome (IBS) - CO2 insufflator and diagnosis of IBS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026616
Enrollment
500
Registered
2017-04-01
Start date
2017-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

None listed

Sponsors

Okazaki Medical Association Public Health Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who are underwent CT colonograhpy for screening colorectal neoplasms

Exclusion criteria

Exclusion criteria: Subjects with gastrointestinal organic disease including colorectal cancer

Design outcomes

Primary

MeasureTime frame
Differences in visual analog scale pain score induced by insufflation of CO2 between IBS group and non-IBS group.

Countries

Japan

Contacts

Public ContactTSUNEYA WADA

Okazaki Medical Association Public Health Center Department of gastroenterology

t-wada@okazaki-med.or.jp0564-52-1572

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026